✦ LIBER ✦

Synchronous Primary Lung Cancer and Epidermal Growth Factor Receptor Mutation

✍ Scribed by Edmond S.K. Ma; Paul N.M. Cheng; Chris L.P. Wong; Anthony P.C. Yim

Book ID: 113472398
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 938 KB
Volume: 90
Category: Article
ISSN: 0003-4975
DOI: 10.1016/j.athoracsur.2010.06.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations in lung cancer

✍ Sharma, Sreenath V.; Bell, Daphne W.; Settleman, Jeffrey; Haber, Daniel A. 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 441 KB

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations in lung cancers

✍ Yasushi Yatabe; Tetsuya Mitsudomi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

Impact of age on epidermal growth factor

Impact of age on epidermal growth factor receptor mutation in lung cancer

✍ Ueno, Tsuyoshi; Toyooka, Shinichi; Suda, Kenichi; Soh, Junichi; Yatabe, Yasushi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Targeting epidermal growth factor recept

Targeting epidermal growth factor receptor in lung cancer

✍ José Baselga; Joan Albanell 📂 Article 📅 2002 🏛 Current Science Inc. 🌐 English ⚖ 604 KB

Exclusive mutation in epidermal growth f

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

✍ Makoto Suzuki; Hisayuki Shigematsu; Toshihiko Iizasa; Kenzo Hiroshima; Yukio Nak 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views

Somatic mutations of epidermal growth fa

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

✍ Hisayuki Shigematsu; Adi F. Gazdar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 540 KB

Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene in lung cancers have generated enormous interest, because they predict for sensitivity to TK inhibitors (TKIs). While mutational status is of great importance in determining response to TKIs, it